Solomon C. Luo, MD, PC
Solomon C. Luo, MD, PC was paid $2.99M by Medicaid between Jan 2018 and Dec 2024, across 46 billing codes. Its largest line is 67028, Intravitreal injection of a pharmacologic agent — 16% of everything it billed.
33Billing provider infoSOLOMON C. LUO, MD, PC
POTTSVILLE, PA 17901
POTTSVILLE, PA 17901
33aNPI1861435174assigned 06/14/2006
33bProvider typeOptometrist
28Total paid$2.99M
24GClaims93,390
24DCodes billed46
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Optometrist providers in Pennsylvania
Rank by total paid#1 of 983
Median peer was paid$20K
This provider vs. median148×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,667 | $4K | |
| 2020 | 3,207 | $95K | |
| 2021 | 22,147 | $679K | |
| 2022 | 20,980 | $700K | |
| 2023 | 25,426 | $897K | |
| 2024incomplete | 18,963 | $611K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 67028 | Intravitreal injection of a pharmacologic agent | 16% | 8,599 | 5,638 | $483K |
| 92134 | 9.7% | 14,674 | 14,261 | $291K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 9.0% | 806 | 699 | $268K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 8.9% | 9,270 | 8,769 | $266K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8.7% | 7,112 | 6,915 | $259K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.3% | 8,875 | 8,279 | $247K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 4.3% | 2,646 | 2,607 | $128K |
| 92235 | 4.0% | 3,256 | 3,144 | $119K | |
| 92250 | 3.7% | 3,807 | 3,674 | $110K | |
| J9035 | Injection, bevacizumab, 10 mg | 3.4% | 4,773 | 3,398 | $102K |
| 92083 | 3.3% | 2,679 | 2,630 | $99K | |
| 65855 | 2.9% | 694 | 573 | $88K |
34 more codes
| V2020 | Frames, purchases | 2.3% | 3,451 | $70K |
| 67210 | 2.3% | 374 | $69K | |
| 99204 | Doctor's office visit, new patient (more involved) | 2.0% | 708 | $60K |
| 92133 | 1.8% | 2,588 | $53K | |
| V2199 | Not otherwise classified, single vision lens | 1.4% | 1,558 | $42K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 1.3% | 1,687 | $39K |
| V2784 | Lens, polycarbonate or equal, any index, per lens | 1.1% | 4,328 | $32K |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 858 | $23K |
| 67228 | <1% | 88 | $23K | |
| 92201 | <1% | 1,794 | $18K | |
| 92020 | <1% | 1,769 | $17K | |
| 92060 | <1% | 491 | $15K | |
| 67145 | <1% | 132 | $15K | |
| 92202 | <1% | 1,406 | $10K | |
| 92136 | <1% | 497 | $6K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 93 | $6K |
| 66821 | <1% | 52 | $5K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 180 | $5K |
| 76514 | <1% | 630 | $4K | |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | <1% | 122 | $3K |
| V2102 | Sphere, single vision, plus or minus 7.12 to plus or minus 20.00d, per lens | <1% | 73 | $3K |
| 67220 | <1% | 12 | $3K | |
| 65600 | <1% | 24 | $2K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 52 | $2K |
| 92015 | Determination of refractive state | <1% | 630 | $1K |
| V2104 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens | <1% | 34 | $909.16 |
| V2299 | Specialty bifocal (by report) | <1% | 24 | $875.52 |
| 76519 | <1% | 16 | $602.26 | |
| S0621 | Routine ophthalmological examination including refraction; established patient | <1% | 13 | $390.00 |
| 92226 | <1% | 816 | $211.34 | |
| 92225 | 0% | 24 | $0.00 | |
| 83861 | 0% | 359 | $0.00 | |
| J7999 | Compounded drug, not otherwise classified | 0% | 1,275 | $0.00 |
| 99024 | 0% | 41 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMARTIN, JEFFREY (PRESIDENT AND OWNER)
| Provider | Location | Paid |
|---|---|---|
| Sight Medical Doctors PLLC | Hauppauge, NY | $14.77M |
| Jeffrey Lee Martin, DMD a Professional Dental Corp. | Shreveport, LA | $2.15M |
| Solomon C. Luo, MD, PC | Wyomissing, PA | $277K |
| Shore Eye Associates PA | Toms River, NJ | $8K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.